Literature DB >> 7033383

Characterization and functional properties of tumor cell lines in accessory cell replacement assays.

E B Walker, L L Lanier, N L Warner.   

Abstract

This study reports the initial phenotypic and functional characterization of a series of cloned, murine, myelomonocytic tumors and their parent cell line WEHI-3, and a group of murine B lymphoma tumors. The tumor cell lines of the myelomonocytic lineage demonstrated the ability to reconstitute a macrophage-depleted, primary in vitro anti-SRBC PFC response, but only marginally enhanced an accessory cell-depleted, ova-primed, lymphocyte proliferation in vitro response. The B lymphoma tumors displayed exactly the reverse functional profile, being highly efficient in reconstitution of the proliferation response, but not supporting the SRBC PFC response. Detailed analysis of the cell surface phenotype of the various B lymphoma tumors used in this study show they display cell surface markers characteristic of normal B lymphocytes but are heterogeneous in their various stages of differential arrest. Future work will concentrate on the orchestration of Ia-mediated and soluble factor-mediated (IL 1) modalities of antigen-triggering of lymphocytes by these B lymphoma and myelomonocytic tumor cell lines.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7033383

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Functional analysis and nucleotide sequence of the promoter region of the murine hck gene.

Authors:  P Lock; E Stanley; D A Holtzman; A R Dunn
Journal:  Mol Cell Biol       Date:  1990-09       Impact factor: 4.272

2.  Caveolin-1 regulates expression of junction-associated proteins in brain microvascular endothelial cells.

Authors:  Li Song; Shujun Ge; Joel S Pachter
Journal:  Blood       Date:  2006-10-05       Impact factor: 22.113

3.  Autogenous production of a hemopoietic growth factor, persisting-cell-stimulating factor, as a mechanism for transformation of bone marrow-derived cells.

Authors:  J W Schrader; R M Crapper
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

4.  Alternatively spliced murine lyn mRNAs encode distinct proteins.

Authors:  E Stanley; S Ralph; S McEwen; I Boulet; D A Holtzman; P Lock; A R Dunn
Journal:  Mol Cell Biol       Date:  1991-07       Impact factor: 4.272

5.  Anti-CD43 inhibition of T cell homing.

Authors:  L M McEvoy; H Sun; J G Frelinger; E C Butcher
Journal:  J Exp Med       Date:  1997-04-21       Impact factor: 14.307

6.  Expression of Thy-1 antigen is not limited to T cells in cultures of mouse hemopoietic cells.

Authors:  J W Schrader; F Battye; R Scollay
Journal:  Proc Natl Acad Sci U S A       Date:  1982-07       Impact factor: 11.205

7.  Two isoforms of murine hck, generated by utilization of alternative translational initiation codons, exhibit different patterns of subcellular localization.

Authors:  P Lock; S Ralph; E Stanley; I Boulet; R Ramsay; A R Dunn
Journal:  Mol Cell Biol       Date:  1991-09       Impact factor: 4.272

8.  Novel vascular molecule involved in monocyte adhesion to aortic endothelium in models of atherogenesis.

Authors:  L M McEvoy; H Sun; P S Tsao; J P Cooke; J A Berliner; E C Butcher
Journal:  J Exp Med       Date:  1997-06-16       Impact factor: 14.307

9.  Fractalkine is expressed in early and advanced atherosclerotic lesions and supports monocyte recruitment via CX3CR1.

Authors:  Moritz Stolla; Jaroslav Pelisek; Marie-Luise von Brühl; Andreas Schäfer; Verena Barocke; Peter Heider; Michael Lorenz; Anca Tirniceriu; Alexander Steinhart; Johann Bauersachs; Paul F Bray; Steffen Massberg; Christian Schulz
Journal:  PLoS One       Date:  2012-08-20       Impact factor: 3.240

10.  Murine gamma interferon activates the release of a macrophage-derived Ia-inducing factor that transfers Ia inductive capacity.

Authors:  E B Walker; V Maino; M Sanchez-Lanier; N Warner; C Stewart
Journal:  J Exp Med       Date:  1984-05-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.